Immune response to SARS-CoV-2 vaccines in patients with multiple sclerosis in Argentina: prospective and multicenter study

被引：0
|
作者：
Vazquez, G. [1 ,2 ]
Lamas, P. [3 ]
Remolins, C. [3 ]
Appiani, F. [4 ]
Martinez, A. [5 ]
Curbelo, M. C. [5 ]
Pirola, D. [6 ]
Natalia, B. [7 ]
Chuluyan, E. [3 ]
Carra, A. [4 ,5 ]
机构：
[1] Favaloro Fdn Hosp, Buenos Aires, DF, Argentina
[2] INECO, Buenos Aires, DF, Argentina
[3] Univ Buenos Aires, Fac Med, CONICET, CEFYBO, Buenos Aires, DF, Argentina
[4] Favaloro Fdn Hosp, Neurosci, Buenos Aires, DF, Argentina
[5] Britann Hosp, Demyelinating Serv, Buenos Aires, DF, Argentina
[6] Favaloro Fdn Hosp, Cent Lab, Buenos Aires, DF, Argentina
[7] GADOR SA, Med & Sci Dept, Buenos Aires, DF, Argentina
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EP1113
引用
收藏
页码：879 / 879
页数：1
相关论文
共 50 条
  • [31] Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines
    Hromic-Jahjefendic, Altijana
    Lundstrom, Kenneth
    Adilovic, Muhamed
    Aljabali, Alaa A. A.
    Tambuwala, Murtaza M.
    Serrano-Aroca, Angel
    Uversky, Vladimir N.
    AUTOIMMUNITY REVIEWS, 2024, 23 (03)
  • [32] Vertical transmission and humoral immune response following maternal infection with SARS-CoV-2: a prospective multicenter cohort study
    Massalha, Manal
    Yefet, Enav
    Rozenberg, Orit
    Soltsman, Sofia
    Hasanein, Jamal
    Smolkin, Tatiana
    Alter, Adi
    Perlitz, Yuri
    Nachum, Zohar
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (09) : 1258 - 1262
  • [33] Divergent Immune Responses to SARS-CoV-2 Vaccines in Immunocompromised Patients
    Jordan, Stanley C.
    Shin, Bong-Ha
    Gadsden, Terry-Ann M.
    Chu, Maggie
    Petrosyan, Anna
    Vo, Ashley
    Ammerman, Noriko
    Sethi, Supreet
    Najjar, Reiad
    Huang, Ed
    Peng, Alice
    Toyoda, Mieko
    Kumar, Sanjeev
    Zhang, Ruan
    TRANSPLANTATION, 2022, 106 (01) : E90 - E91
  • [34] COVACiMS Study: SARS-CoV-2 vaccine effectiveness in patients with multiple sclerosis
    Ladeira, F.
    Nobrega, C.
    Capela, C.
    Mendes, I.
    Salavisa, M.
    Cerqueira, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 198 - 198
  • [35] Immune response in SARS-CoV-2
    Luis Aguilar-Shea, Antonio
    Gallardo Mayo, Cristina
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2020, 9 (09) : 5074 - 5075
  • [36] SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis
    Pinar Morales, R.
    Ramirez Rivas, M. A.
    Barrero Hernandez, F. J.
    NEUROLOGIA, 2021, 36 (09): : 698 - 703
  • [37] Vaccination against SARS-CoV-2 in patients with multiple sclerosis
    Costa-Frossard, Lucienne
    Garcia-Dominguez, Jose M.
    Moreno-Torres, Irene
    Fortun, Jesus
    Villar, Luisa M.
    Meca-Lallana, Virginia
    REVISTA DE NEUROLOGIA, 2021, 72 (07) : 250 - 260
  • [38] Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
    Woopen, Christina
    Schleussner, Katharina
    Akgun, Katja
    Ziemssen, Tjalf
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [39] Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
    M. Allman
    E. Tallantyre
    N. P. Robertson
    Journal of Neurology, 2022, 269 : 2259 - 2261
  • [40] Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
    Allman, M.
    Tallantyre, E.
    Robertson, N. P.
    JOURNAL OF NEUROLOGY, 2022, 269 (04) : 2259 - 2261
12345